首页> 美国卫生研究院文献>other >The prognostic utility of tests of platelet function for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation.
【2h】

The prognostic utility of tests of platelet function for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation.

机译:血小板功能测试对已确定的心血管或脑血管疾病患者的阿司匹林抵抗检测的预后效用:系统评价和经济评价。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDThe use of aspirin is well established for secondary prevention of cardiovascular disease. However, a proportion of patients suffer repeat cardiovascular events despite being prescribed aspirin treatment. It is uncertain whether or not this is due to an inherent inability of aspirin to sufficiently modify platelet activity. This report aims to investigate whether or not insufficient platelet function inhibition by aspirin ('aspirin resistance'), as defined using platelet function tests (PFTs), is linked to the occurrence of adverse clinical outcomes, and further, whether or not patients at risk of future adverse clinical events can be identified through PFTs.
机译:背景技术阿司匹林在心血管疾病的二级预防中的用途已被广泛确立。但是,尽管接受了阿司匹林治疗,但仍有一部分患者反复发生心血管事件。尚不确定这是否是由于阿司匹林固有的不能充分改变血小板活性的缘故。本报告旨在调查使用血小板功能测试(PFT)定义的阿司匹林对血小板功能的抑制不足(“阿司匹林抵抗”)是否与不良临床结果的发生有关,以及是否存在风险的患者未来不良临床事件的发生可以通过PFT进行识别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号